Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,167 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $375.94 | 29 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $239.24 | 9 | $0 (2023) |
| ABBVIE INC. | $197.72 | 12 | $0 (2023) |
| Alkermes, Inc. | $179.30 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $56.28 | 2 | $0 (2024) |
| Lundbeck LLC | $49.86 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $46.44 | 2 | $0 (2022) |
| ITI, Inc. | $22.63 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.08 | 2 | Janssen Pharmaceuticals, Inc ($24.58) |
| 2023 | $181.87 | 7 | Vanda Pharmaceuticals Inc. ($92.01) |
| 2022 | $556.54 | 27 | Otsuka America Pharmaceutical, Inc. ($196.49) |
| 2021 | $389.92 | 28 | AbbVie Inc. ($180.06) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Neuroscience | ||||||
| 06/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: CNS | ||||||
| 05/23/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/26/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Neuroscience | ||||||
| 01/09/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/17/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/10/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: CNS | ||||||
| 09/28/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/19/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.67 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/18/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $55.26 | General |
| Category: CNS | ||||||
| 06/06/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CNS | ||||||
| 05/23/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 121 | $20,810 | $7,021 |
| 2021 | 2 | 28 | 200 | $26,124 | $9,061 |
| 2020 | 3 | 38 | 185 | $28,785 | $9,328 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 121 | $20,810 | $7,021 | 33.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 13 | 94 | $11,750 | $4,774 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 106 | $14,374 | $4,287 | 29.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 13 | 77 | $9,405 | $4,168 | 44.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 75 | $14,925 | $3,978 | 26.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 33 | $4,455 | $1,182 | 26.5% |
About Kenneth Zimmerman, PMHNP
Kenneth Zimmerman, PMHNP is a Psychiatric/Mental Health healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306998141.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kenneth Zimmerman, PMHNP has received a total of $1,167 in payments from pharmaceutical and medical device companies, with $39.08 received in 2024. These payments were reported across 64 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,167).
As a Medicare-enrolled provider, Zimmerman has provided services to 78 Medicare beneficiaries, totaling 506 services with total Medicare billing of $25,409. Data is available for 3 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Eugene, OR
- Active Since 01/18/2007
- Last Updated 06/26/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306998141
Products in Payments
- REXULTI (Drug) $236.52
- HETLIOZ (Drug) $209.24
- VRAYLAR (Drug) $195.72
- ABILIFY MYCITE (Drug) $150.31
- LYBALVI (Drug) $100.20
- ARISTADA (Drug) $79.10
- SPRAVATO (Drug) $56.28
- BELSOMRA (Drug) $46.44
- ABILIFY MAINTENA (Drug) $38.97
- FANAPT (Drug) $30.00
- CAPLYTA (Drug) $22.63
- VIIBRYD (Drug) $2.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Eugene
Ms. Mary Leyda, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,083
Christopher Worlton, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,033
Mr. James Akins, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,542
Ms. Amber Benson, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,628
Jeffrey Sperla, Np, NP
Psychiatric/Mental Health — Payments: $1,137
Katherine Leatherman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,097